title: Neurogenic stress cardiomyopathy associated with subarachnoid hemorrhage.
abstract: Cardiac manifestations are recognized complications of subarachnoid hemorrhage. Neurogenic stress cardiomyopathy is one complication that is seen in acute subarachnoid hemorrhage. It can present as transient diffuse left ventricular dysfunction or as transient regional wall motion abnormalities. It occurs more frequently with neurologically severe-grade subarachnoid hemorrhage and is associated with increased morbidity and poor clinical outcomes. Managing this subset of patients is challenging. Early identification followed by a multidisciplinary team approach can potentially improve outcomes.
authors.forename: Sowmya
authors.initials: S
authors.lastname: Pinnamaneni
authors.forename: Tanya
authors.initials: T
authors.lastname: Dutta
authors.forename: Joshua
authors.initials: J
authors.lastname: Melcer
authors.forename: Wilbert S
authors.initials: WS
authors.lastname: Aronow
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D017209:Apoptosis; D009202:Cardiomyopathies / Q000503:physiopathology* / Q000628:therapy; D002316:Cardiotonic Agents / Q000627:therapeutic use; D002395:Catecholamines / Q000378:metabolism; D004562:Electrocardiography; D006801:Humans; D007423:Intra-Aortic Balloon Pumping; D032383:Myocytes, Cardiac / Q000473:pathology; D020097:Natriuretic Peptide, Brain / Q000097:blood; D011379:Prognosis; D013345:Subarachnoid Hemorrhage / Q000503:physiopathology*; D019210:Troponin I / Q000097:blood; D018487:Ventricular Dysfunction, Left / Q000503:physiopathology
chemical_list: D000319:Adrenergic beta-Antagonists; D002316:Cardiotonic Agents; D002395:Catecholamines; D019210:Troponin I; D020097:Natriuretic Peptide, Brain
keywords: Takotsubo's cardiomyopathy; neurogenic stress cardiomyopathy; neurogenic stunned myocardium; stress cardiomyopathy; subarachnoid hemorrhage